HYPERKERATOSIS FOLLICULARIS ET PARAFOLLICULARIS

This adverse event was reported 17 times

These drugs are most commonly taken by patients reporting HYPERKERATOSIS FOLLICULARIS ET PARAFOLLICULARIS:

# Drug Count
0 ATENOLOL 5
1 CANDESARTAN CILEXETIL 5
2 DEXLANSOPRAZOLE 5
3 DIMENHYDRINATE 5
4 EZETIMIBE 5
5 HUMAN IMMUNOGLOBULIN G 5
6 INSULIN DEGLUDEC 5
7 METFORMIN 5
8 METFORMIN ER 500 MG 5
9 METFORMIN ER 750 MG 5
See all common drugs associated with HYPERKERATOSIS FOLLICULARIS ET PARAFOLLICULARIS

HYPERKERATOSIS FOLLICULARIS ET PARAFOLLICULARIS is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 PRAZIQUANTEL 1 0.0033
1 PSYLLIUM HUSK 1 0.0007
2 DIMENHYDRINATE 5 0.0005
3 HUMAN IMMUNOGLOBULIN G 5 0.0002
4 INSULIN DEGLUDEC 5 0.0002
5 CANDESARTAN CILEXETIL 5 0.0002
6 TRAMADOL HYDROCHLORIDE 5 0.0001
7 TRETINOIN 1 0.0001
8 DEXLANSOPRAZOLE 5 0.0001
9 EZETIMIBE 5 0.0001
See all drugs enriched for association with HYPERKERATOSIS FOLLICULARIS ET PARAFOLLICULARIS

HYPERKERATOSIS FOLLICULARIS ET PARAFOLLICULARIS is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Anthelmintic [EPC] 1 0.0003
1 Human Immunoglobulin G [EPC] 5 0.0002
2 Dietary Cholesterol Absorption Inhibitor [EPC] 5 0.0001
3 beta-Adrenergic Blocker [EPC] 5 0.0000
4 Insulin Analog [EPC] 6 0.0000
5 Proton Pump Inhibitor [EPC] 5 0.0000
6 Aldosterone Antagonist [EPC] 1 0.0000
7 Xanthine Oxidase Inhibitor [EPC] 1 0.0000
8 Mood Stabilizer [EPC] 1 0.0000
9 Alkylating Drug [EPC] 1 0.0000
See all drug classes enriched for association with HYPERKERATOSIS FOLLICULARIS ET PARAFOLLICULARIS